ReviewPharmaceutics2026

Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review.

Dan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.